Summary
(S)-UH-301 [(S)-5-fluoro-8-hydroxy-2-(dipropylamino)-tetralin, 0.5–4.0 mg/kg i.V.] did not significantly alter the firing rate of 5-hydroxytryptamine (5-HT) containing neurons in the dorsal raphe nucleus (DRN) as a group, although some individual cells were activated whereas others were depressed. However, (S)-UH-301 (2.0mg/kg i.v.) consistently reversed the inhibition of DRN-5-HT cells produced by the selective 5-HT1A receptor agonist (R)-8-OH-DPAT (0.5 μg/kg i.v.) and the dose-response curve for this effect of (R)-8-OH-DPAT was markedly shifted to the right by pretreatment with (S)-UH-301 (1.0mg/kg i.v.). These results support the notion that (S)-UH-301 acts as an antagonist at central 5-HT1A receptors.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Aghajanian GK, Wang RY, Barban J (1978) Serotonergic and non-serotonergic neurons of the dorsal raphe: reciprocal changes in firing induced by peripheral nerve stimulation. Brain Res 153: 169–175
Arborelius L, Chergui K, Murase S, Nomikos GG, Backlund Höök B, Chouvet G, Hacksell U, Svensson TH (1993) The 5-HT1A receptor selective ligands, (R)-8-OH-DPAT and (S)-UH-301, differentially affect the activity of midbrain dopamine neurons. Naunyn Schmiedebergs Arch Pharmacol 347: 353–362
Arborelius L, Svensson TH (1992) Acute effects of (R)-8-OH-DPAT and a novel 5-HT1A receptor antagonist, UH-301, on the cell firing of dorsal raphe (DRN) 5-HT neurons and DA neurons in the ventral tegmental area (VTA). Behav Pharmacol 3 (S1): 40
Björk L, Cornfield LJ, Nelson DL, Hillver S-E, Andén N-E, Lewander T, Hacksell U (1991) Pharmacology of the novel 5-hydroxytryptamine1A receptor antagonist (S)-5-fluoro-2-(dipropylamino)-tetralin: inhibition of (R)-8-hydroxy-2-(dipropylamino)-tetralin-induced effects. J Pharmacol Exp Ther 258: 58–65
Blier P, Steinberg S, Chaput Y, de Montigny C (1988) Electrophysiological assessment of putative antagonists of 5-hydroxytryptamine receptors: a single-cell study in the rat dorsal raphe nucleus. Can J Physiol Pharmacol 67: 98–105
Chaput Y, de Montigny C (1988) Effects of the 5-hydroxytryptamine1 receptor antagonist, BMY 7378, on 5-hydroxytryptamine neurotransmission: electrophysiological studies in the rat central nervous system. J Pharmacol Exp Ther 246: 359–370
Cornfield LJ, Lambert G, Arvidsson L-E, Mellin C, Vallg»rda J, Hacksell U, Nelson DL (1991) Intrinsic activity of enantiomers of 8-hydroxy-2-(di-n-propylamino)tetralin and its analogs at 5-hydroxytryptamine1A receptors that are negatively coupled to adenylate cyclase. Mol Pharmacol 39: 780–787
Ferré S, Artigas F (1993) Dopamine D2 receptor-mediated regulation of serotonin extracellular concentration in the dorsal raphe nucleus of freely moving rats. J Neurochem 61: 772–775
Fletcher A, Bill DJ, Bill SJ, Cliffe IA, Dover GM, Forster EA, Haskins JT, Jones D, Mansell HL, Reilly Y (1993) WAY 100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors. Eur J Pharmacol 237: 283–291
Greuel JM, Glaser T (1992) The putative 5-HT1A receptor antagonists NAN-190 and BMY 7378 are partial agonists in the rat dorsal raphe nucleus in vitro. Eur J Pharmacol 211: 211–219
Hillver S-E, Björk L, Li Y-L, Svensson B, Ross S, Andén N-E, Hacksell U (1990) (S)-5-fiuoro-8-hydroxy-2-(dipropylamino)-tetralin: a putative 5-HT1A-receptor antagonist. J Med Chem 33: 1541–1544
Hjorth S, Magnusson T (1988) The 5-HT1A receptor agonist, 8-OH-DPAT, preferentially activates cell body 5-HT autoreceptors in rat brain in vivo. Naunyn Schmiedebergs Arch Pharmacol 338: 463–471
Hutson PH, Sarna GS, O'Connell MT, Curzon G (1989) Hippocampal 5-HT synthesis and release in vivo is decreased by infusion of 8-OHDPAT into the nucleus raphe dorsalis. Neurosci Lett 100: 276–280
Jacobs BL, Azmitia EC (1992) Structure and function of brain serotonin system. Physiol Rev 72: 165–229
Jolas T, Haj-Dahmane S, Lanfumey L, Fattaccini CM, Kidd EJ, Adrien J, Gozlan H, Guardiola-Lemaitre B, Hamon M (1993) (−) Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain. Naunyn Schmiedebergs Arch Pharmacol 347: 453–463
Junzo O, Shimizu K (1978) Occurrence of dopamine-containing neurons in the midbrain raphe nuclei of the rat. Neurosci Lett 8: 317–320
Kalén P, Skagerberg G, Lindvall O (1988) Projections from the ventral tegmental area and mesencephalic raphe to the dorsal raphe nucleus in the rat. Exp Brain Res 73: 69–77
Lejeune F, Rivet J-M, Gobert A, Canton H, Millan MJ (1993) WAY100,135 and (−)- tertatolol act as antagonists at both 5-HT1A autoreceptors and postsynaptic 5-HT1A receptors in vivo. Eur J Pharmacol 240: 307–310
Miquel M-C, Doucet E, Boni C, El Mestikawy S, Matthiessen L, Daval G, Vergé D, Hamon M (1991) Central serotonin1A receptors: respective distributions of encoding mRNA, receptor protein and binding sites by in situ hybridisation histochemistry, radioimmunohistochemistry and autoradiographic mapping in the rat brain. Neurochem Int 19: 453–465
Nomikos GG, Arborelius L, Svensson TH (1992) The novel 5-HT1A receptor antagonist (S)-UH-301 prevents (R)-8-OH-DPAT-induced decrease in interstitial concentrations of serotonin in the rat hippocampus. Eur J Pharmacol 216: 373–378
Paxinos G, Watson C (1986) The rat brain in stereotaxic coordinates, 2nd edn. Academic Press, Sydney
Pazos A, Palacios JM (1985) Quantitative autoradiographic mapping of serotonin receptors in the rat brain. I. Serotonin-1 receptors. Brain Res 346: 205–230
Sinton CM, Fallon SL (1988) Electrophysiological evidence for a functional differentiation between subtypes of the 5-HT1 receptor. Eur J Pharmacol 157: 173–181
Sotelo C, Cholley B, El Mestikawy S, Gozlan H, Hamon M (1990) Direct immunohistochemical evidence of the existence of 5-HT1A autoreceptors on serotonergic neurons in midbrain raphe nuclei. Eur J Neurosci 2: 1144–1154
Sprouse JS, Aghajanian GK (1987) Electrophysiological responses of sertonergic dorsal raphe neurons to 5-HT1A and 5-HT1B agonist. Synapse 1: 3–9
Sprouse JS, Aghajanian GK (1988) Responses of hippocampal pyramidal cells to putative serotonin 5-HT1A and 5-HT1B agonists: a comparative study with dorsal raphe neurons. Neuropharmacology 27: 707–715
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Arborelius, L., Höök, B.B., Hacksell, U. et al. The 5-HT1A receptor antagonist (S)-UH-301 blocks the (R)-8-OH-DPAT-induced inhibition of serotonergic dorsal raphe cell firing in the rat. J. Neural Transmission 96, 179–186 (1994). https://doi.org/10.1007/BF01294785
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01294785